Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland

Table 5 Number of hypnotics/anxiolytics prescriptions in different age groups

Age	All incident patients issued 1, 2–4 or 5+ prescriptions				Multimorbid incident patients issued 1, 2–4 or 5+ prescriptions
groups	1	2–4	5+	All	1	2–4	5+	All
<1–19	163	52	20	235	82	28	7	117
20–29	373	177	40	590	225	124	29	378
30–39	484	244	82	810	348	188	62	598
40–49	418	232	93	743	335	187	78	600
50–59	431	273	92	796	362	243	81	686
60–69	298	213	60	571	262	198	54	514
70–79	166	128	46	340	151	119	44	314
80+	92	104	24	220	86	101	23	210
Total	2,425	1,423	457	4,305	1,851	1,188	378	3,417

Number of hypnotics and/or anxiolytics prescriptions in 2011 both in the total population of incident patients and in multimorbid incident patients solely

ISSN: 2731-4553